Acetylcholine: a neurotransmitter for learning and memory?

Brain Research Reviews

Volumn 21, Issue 3, 1995, Pages 285-300

  Blokland, Arjan ^a  

^a Institute for Neurobiology   (Germany)

Author keywords

Acetylcholine; Alzheimer's disease; Cholinergic; Cognition; Dopamine; Glutamate; Learning; Memory; Muscarine; Nicotin; Serotonin

Indexed keywords

ACETYLCHOLINE; AFX 116; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEXAMPHETAMINE; DOPAMINE; GLUTAMIC ACID; HEMICHOLINIUM 3; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; PIRENZEPINE; QUINPIROLE; SCOPOLAMINE; SEROTONIN; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; CHOLINERGIC SYSTEM; HUMAN; HUMAN TISSUE; LEARNING; MEMORY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029553116     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0173(95)00016-X     Document Type: Review

References (135)

1. Excitatory amino acids and memory: evidence from research on Alzheimer's disease and behavioral pharmacology
2. Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats
3. Effects of disrupting the cholinergic system on short-term spatial memory in rats
4. Behavioural pharmacology of 5-HT3 receptor ligands
5. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates
6. The cholinergic hypothesis of geriatric memory dysfunction
7. The cholinergic hypothesis: a historical overview, current perspective, and future directions
8. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
9. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia
10. Receptor subtype-specific dopaminergic agents and conditioned behavior
11. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis
12. Effects of intro-hippocampal scopolamine injections in a repeated spatial acquisition task in the rat
13. Age-related changes in spatial discrimination learning performance in Lewis rats
14. Spatial learning deficit and reduced hippocampal ChAT activity in rats after an icv injection of streptozotocin
15. Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampo-entorhinal area upon passive avoidance learning in young rats
16. Choline and cholinergic neurons
17. Choline acetyltransferase activity and histopathology of frontal cortex from biopsies of demented patients
18. Memory and the septo-hippocampal cholinergic system in the rat
19. Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade
20. Effects of dopaminergic drugs on working and reference memory in rats
21. Continuous icv infusion of scopolamine impairs sustained attention of rhesus monkeys
22. 1Areceptors in the dorsal hippocampas impairs acquisition and performance of a spatial task in a water maze
23. 8-Hydroxy-2-(di-n-prpylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HTIA receptors
24. Glutamate neurotoxicity in cortical cell culture
25. 5-HTIA receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task
26. Cholinergic function and intelectual decline in Alzheimer's disease
27. Effects of concomitant nicotinic and muscarinic blockade on spatial memory disturbances in rats are purely additive: evidence from the Morris water task
28. The role of NMDA receptors in information processing
29. Pharmacological mechanisms and animal models of cognition
30. Behavioural effects of intraventricularly administered vasopressin and vasopressin fragments
31. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system
32. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics
33. Effects of nicotine on spatial memory deficits in rats with septal lesions
34. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory
35. The cholinergic synapse and the site of memory
36. Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin
37. 2 antagonists: novel structures and pharmacology
38. Human memory and the cholinergic system: a relationship to aging?
39. Scopolamine and the control of attention in humans
40. Neural transplantation in animal models of dementia
41. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions
42. The functional role of the mesotelencephalic dopamine system
43. Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats
44. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
45. Scopolamine effects on memory retention in mice: a model of dementia?
46. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative
47. Interaction of cholinergic-dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks
48. Local modulation of basal forebrain: effects on working and reference memory
49. Blockade of spatial learning by the ml muscarinic antagonist pirenzipine
50. The cholinergic hypothesis of memory: a review of animal experiments
51. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis
52. Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit nictitating membrane response
53. Neuromodulation and cortical function: modeling the physiological basis of behavior
54. Peony and its major constituent, peaniflorin, improve radial maze performance
55. Effects of cholinergic-rich grafts on radial maze performance after excitotoxic lesions of the forebrain cholinergic projection system. II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery
56. The cholinergic model of dementia, Alzheimer type: progression from the unitary transmitter concept
57. Scopolamine injected into the rat amygdala impairs working memory in the double Y-maze
58. Long-term potentiation and the mechanisms of memory
59. The effects of serotonergic drugs on short-term spatial memory in rats
60. Are postsynaptic 5-HTIA receptors involved in the anxiolytic effects of 5-HTIA receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
61. Low dose of scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination
62. Influence of prefeeding and scopolamine upon performance in a delayed matching-to-position task
63. Non-Alzheimer-type pattern of brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy
64. Functions of the frontal cortex of the rat
65. The cholinergic neurotransmitter system in human learning and memory: a review
66. Cerebellar contributions to instrumental learning
67. Mesocorticolimbic dopaminergic network: functional and regulatory roles
68. Nicotinic systems and cognitive function
69. Nicotine interactions with dopamine agonists: effects on working memory function
70. Serotonin, memory, and the aging brain
71. Cholinergic function in the aged brain: implications for the treatment of memory impairments associated with aging
72. Glutamate: its role in learning, memory, and the aging brain
73. Dissociating learning and performance: drug and hormone enhancement of memory storage
74. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands
75. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease
76. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease
77. Selectivity of pirenzipine in the central nervous system. II differential effects of pirenzipine and scopolamine on performance of a representational memory task
78. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch. 1–6)
79. 14C-Serotonin and 3H-norepinephrine into the hypothalamus of the rat: diffusion into tissue and ventricles
80. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
81. Central versus peripheral effects of muscarinic antagonists: the limitations of quartemary ammonium derivatives
82. Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands
83. Differential effects of scopolamine and mecamylamine on working and reference memory in the rat
84. Selective impairment of learning and memroy and blockade of long-term potentiation of an N-methyl-d-aspertate receptor antagonist, AP5
85. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function
86. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron
87. Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms
88. Subtypes of dopamine receptors involved in the mechanism of reinforcement
89. Alzheimer's disease: a correlative study
90. Spatial teaming impairments in rats with selective immunolesion of the forebrain cholinergic system
91. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in the rat brain cortex
92. Blockade of hippocampal nicotinic receptors impairs working but not reference memory in rats
93. Blockade of hippocampal M, muscarinic receptors impairs working memory performance of rats
94. Quinpirole and d-amphetamine administration posttraining enhances memory on spatial and cued discriminations in a water maze
95. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease
96. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
97. (Letter to the Editor)
98. Convergent cholinergic activities in aging and Alzheimer's disease
99. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
100. Purkinje cells of adult rat cerebellum express nerve growth factor receptor immunoreactivity: light microscopic observations
101. 1A receptor in the rat brain: correlation with receptor binding
102. Comparative behavioral effects of several anti-cholinergic agents in rats
103. Spatial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats: effects of chronic treatment with acetyl-l-camitine
104. 2-muscarinic receptor antagonist in aged memory-impaired rats
105. Pharmacological consequences of nicotinergic plus serotonergic manipulations
106. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes
107. An analysis of cholinoceptive neurons in the hippocampal formation by direct microinfusion
108. Evidence against a specific effect of cholinergic drugs on spatial memory in primates
109. Cholinergic drugs and human cognitive performance
110. Nicotine and tetrahydroaminoacredine: evidence for improved attention in patients with dementia of the Alzheimer type
111. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type
112. Combined serotonergic-cholinergic lesions do not disrupt memory in rats
113. Taking stock of cognitive enhancers
114. Cognitive functions of cortical ACh: lessons from studies on trans-synaptic modulation of activated efflux
115. Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification
116. Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming ana recall
117. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzipine
118. Animal models of Alzheimer's disease: experimental cholinergic denervation
119. Facilitation of glutamate receptors enhances memory
120. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
121. Effect of sex and age on brain monoamines and spatial learning in rats
122. Radial-arm maze deficits produced by colchicine administration into the area of the nucleus basalis are ameliorated by cholinergic agonists
123. Behavioural, histochemical and biochemical consequences of selective immunolesions in dis crete regions of the basal forebrain cholinergic system
124. Selective fimbria lesions impair acquisition of working and reference memory of rats in a complex spatial discrimination task
125. The behavioral neurobiology of learning and memory: a conceptual reorientation
126. Basal forebrain lesions in monkeys disrupt attention but not learning and memory
127. Attenuation of stimulus sensitivity induced by scopolamine
128. Cholinergic control of cognitive resources
129. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-Saporin injections into the basal forebrain of rats
130. Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats
131. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning
132. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons